ClinicalTrials.gg
Enrolling by invitationNCT07484958Updated Mar 20, 2026

Co-designing a Stroke Rehabilitation Trial Toolkit

An observational study in Stroke, Rehabilitation and Co-design, sponsored by University of Plymouth. Enrolling by invitation at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-20.

Sponsored by University of Plymouth · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
38
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 372 studies in Stroke with a site in United Kingdom — 60 open to participants now, 80 under way, 8 of them phase 3. Stroke · United Kingdom.

Planned enrollment
91st of 115
38 · median 198
Started
2026
with 5 others
Observational
115 of 372
26 open now
Primary completion
2027-01
later than 47 of 79 live
Registered
363rd of 372
by date

Among the 372 studies in Stroke with a site in United Kingdom, this one is the 91st largest by planned enrollment of the 115 observational ones that give a count, is one of 6 that started in 2026, is one of 115 observational ones, reaches primary completion later than 47 of the 79 other live ones, and was the 363rd registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

60 of the 372 studies in Stroke with a site in United Kingdom are open now. Recruiting first, the newest first:

55 more — sign in →

All 60 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 372 studies in Stroke with a site in United Kingdom, or all of them as a file.
02

Study summary

Clinical trials are a type of research that tests if a treatment works well and is safe, so future care can be improved. In stroke rehabilitation, clinical trials are essential for improving the lives of stroke survivors. Clinical trials follow detailed plans called protocols, that explain what activities should be done, by whom and when. This makes sure everyone in the trial does things the same way, so results are fair and consistent. Sometimes, stroke survivors or staff may not follow the trial protocol exactly. For example, someone might miss a session or do different exercises. This is called low adherence. There are many reasons this can happen; the exercises or schedule may be too hard, the trial or activities do not match what stroke survivors or staff need, prefer, or find helpful in real life. If protocols are not followed properly, the trial results of clinical trials may not be reliable. This can slow down the process of getting better treatments into hospitals and make it harder to improve rehabilitation for future stroke survivors.

Previous research has looked at what helps and gets in the way of adhering to protocols during hospital-based stroke rehabilitation trials. The research has identified many factors, including the healthcare system, hospital environment, staff, patients and the rehabilitation activities or schedules. Most of this research focused on the views of staff involved, meaning important perspectives may be missing from others involved in stroke rehabilitation trials.

The investigators' study aims to change that. The investigators want to hear from people whose voices are often overlooked: stroke survivors, their family and friends, stroke rehabilitation staff and healthcare leaders working in the NHS, stroke rehabilitation researchers, staff working in Integrated Care Boards (who help plan and coordinate NHS services in local areas) and representatives from organisations who fund stroke rehabilitation research. The investigators will use a process called co-design. This means working together to develop a toolkit to help improve adherence in future stroke rehabilitation trials.

Toolkits are already used in healthcare to help people do things better. For example, changing how care is given, supporting patients, or helping health teams work more smoothly. But currently, there is no toolkit designed specifically to help improve adherence to stroke rehabilitation trial protocols.

This research aims to design a toolkit together. The toolkit will be shaped by a wide range of voices, especially those from underrepresented groups, and made in a way that's easy to understand and use.

By addressing potential barriers early on, the investigators hope the toolkit will make it easier for future stroke rehabilitation trials to succeed, leading to better recovery and quality of live for stroke survivors.

Read the detailed description

Robust stroke rehabilitation trials are essential for advancing evidence-based practice. These trials rely on adherence to detailed protocols that specify the treatment content, delivery, frequency, and data collection methods. However, when protocols are not adhered to (low adherence) this compromises the reliability and validity of trial outcomes, leading to research waste and delays translating evidence into clinical practice, ultimately hindering recovery for stroke survivors.

A mixed-methods systematic review of hospital-based rehabilitation clinical trials identified multiple barriers and facilitators to protocol adherence for hospital-based rehabilitation trials: innovation (rehabilitation intervention), outer setting (healthcare system), inner setting (hospital/organisation), individuals (leaders, intervention deliverers and recipients) and implementation (activities/strategies to deliver the intervention). The systematic review provides critical insights to inform future trial design and implementation. However, the findings predominantly reflect staff perspectives and are drawn from individual stroke rehabilitation trials, potentially limiting generalisability across broader contexts. Thus, the aim of the research is to gather underrepresented voices to understand the knowledge, skills, techniques and behaviours needed to improve and maintain adherence to stroke rehabilitation protocols. The investigators will work together with stroke survivors, family member/friend of stroke survivor, stroke rehabilitation staff and researchers, healthcare leaders, staff from Integrated Care Board/Systems and funders (hereon in referred to as research partners) using Experience-Based Co-Design (EBCD). EBCD brings together lived experience, lived expertise and professional experience to learn from each other to design a toolkit that meets the needs and preferences of all.

Toolkits have been widely used in health as a way of knowledge translation, aim to improve behaviours among healthcare staff, consumers, organisations, policy makers and the public. They typically consist of a collection of resources practical tools designed to support the implementation and uptake of a treatment or process. The content and format of toolkits can vary depending on the health condition, target users, clinical setting, and individual needs and preferences. However, there is no existing toolkit to help improve adherence in stroke rehabilitation clinical trials. This study specifically addresses the need to develop a toolkit to optimise adherence to inpatient stroke rehabilitation clinical trial protocols.

The investigators will co-design a toolkit based on the diverse needs and priorities of the research partners and will incorporate evidence-based methods to ensure reach to underserved groups. They will ensure that the languages, strategies and information is accessible and relatable to different communities of individuals.

The investigators will consider potential barriers and solutions to implementation throughout to ensure successful adoption of a toolkit in future inpatient stroke rehabilitation trials.

03

Conditions studied

  • Stroke
  • Rehabilitation
  • Co-design

Browse trials for

Keywords

  • Stroke rehabilitation
  • Co-design
  • Adherence
  • Clinical trials
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Stroke survivors, family member or friend of stroke survivor, stroke rehabilitation staff, healthcare leaders, stroke rehabilitation researchers, funders of stroke rehabilitation research.

Eligibility criteria

Participants will be eligible if they meet the following criteria:

8.1.1 Inclusion criteria stroke survivors

  • Adults (aged 18+) who have experienced a stroke. No time limit since stroke
  • Able to provide
  • Sufficient communication abilities (verbal or non-verbal, with or without support) to participate in co-design activities
  • Received inpatient stroke rehabilitation after their stroke
  • Has or has not previously participated in a stroke rehabilitation clinical trial during their hospital-based stroke rehabilitation
  • Willing to participate in co-design activities and share their perspectives.

8.1.2 Inclusion criteria family member/friend of stroke survivor

  • Adults (aged 18+) who are a family member, friend, or informal caregiver of a stroke survivor.
  • Able and willing to provide informed consent.
  • Willing to participate in co-design activities and share their perspectives.

8.1.3 Inclusion criteria stroke rehabilitation staff

  • Registered staff currently working in stroke rehabilitation who routinely prescribe and/or supporting stroke rehabilitation activities (e.g., physiotherapist, occupational therapist, rehabilitation nurses, rehabilitation physician)
  • ≥6 months of experience in hospital-based stroke rehabilitation settings
  • Employed in an organisation that provides NHS hospital-based stroke rehabilitation services
  • Willing to participate in co-design activities and share their perspectives.

8.1.4 Inclusion criteria healthcare leaders (e.g., Managers, Administrators, Policy Makers)

  • Individuals who are accountable and responsible for the operational, clinical, and/or strategic delivery of stroke rehabilitation, rehabilitation and/or therapy services within a NHS hospital
  • Individuals working in an Integrated Care Board with rehabilitation and/or research in their portfolio
  • Experience in implementing/influencing stroke rehabilitation policy/service delivery
  • Willing to participate in co-design activities and share their perspectives.

8.1.5 Inclusion criteria stroke rehabilitation researchers

  • Active researchers with experience in designing, conducting and evaluating stroke rehabilitation or physical rehabilitation research
  • Affiliated with academic or research institutions
  • Willing to participate in co-design activities and share their perspectives.

8.1.6 Inclusion criteria for funders

  • Currently employed, contracted to, or formally affiliated with a research funding organisation that reviews, commissions or funds stroke rehabilitation research (e.g., NIHR, Stroke Association, research councils, medical research councils, professional bodies or research charities)
  • Direct involvement in decision-making, monitoring or governance of stroke rehabilitation research within the past two years
  • Experience with funding processes related to stroke rehabilitation, rehabilitation or clinical trial oversight

8.2 Exclusion Criteria

Participants will not be eligible if they meet any the following criteria:

8.2.1 Exclusion criteria for stroke survivors

  • Significant cognitive and/or communication impairment that preclude meaningful participation, even with support
  • Exhibiting aggression or other behaviour issues that put themselves and others at risk
  • Medical instability that would make participation unsafe or overly burdensome
  • Currently enrolled in another research study that could confound participation or data collection
  • Non-English speaking (research study does not offer language support).

8.2.2 Exclusion criteria for family member/friend of stroke survivor

  • Not family member or friend of a stroke survivor
  • Significant emotional distress or trauma that would be exacerbated by participation.
  • Non-English speaking (research study does not offer language support).

8.2.3 Exclusion criteria for stroke rehabilitation staff

  • Currently under disciplinary review or leave of absence.
  • ≤6 experience in NHS inpatient stroke rehabilitation
  • Inability to commit time to the study activities.

8.2.4 Exclusion criteria for healthcare leaders (e.g., Managers, Administrators, Policy Makers)

  • Not in a leadership or decision-making role within an organisation that provides NHS inpatient stroke rehabilitation or rehabilitation/therapy services
  • Not working in an Integrated Care Board/System
  • No experience in implementing or influencing stroke rehabilitation policy or service delivery
  • Conflict of interest with study funders or researchers.

8.2.5 Exclusion criteria for stroke rehabilitation researchers

  • No direct experience with stroke or rehabilitation research in the past two years.
  • No experience of hospital-based stroke or physical rehabilitation research in the past two years
  • Participation that would lead to conflicts of interest with the research team or funders.

8.2.6 Exclusion criteria for funders

  • Not employed by or formally affiliated with a research funding organisation that reviews, commissions or funds stroke rehabilitation research (e.g., NIHR, Stroke Association, research councils, medical research councils, professional bodies or research charities)
  • No direct involvement in decision-making, monitoring or governance of stroke rehabilitation research within the past two years
  • Conflict of interest with the research team or institutions delivering this study
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
38 participants (estimated)
Patient registry
No

Groups and cohorts

  • Stroke survivors

    Stroke survivors aged 18 years and over

    Other: Co-designing a stroke rehabilitation toolkit

  • Stroke rehabilitation staff

    Staff with more than 6 months experience of working in inpatient stroke rehabilitation, e.g., nurse, occupational therapist, physiotherapist, rehabilitation physician

    Other: Co-designing a stroke rehabilitation toolkit

  • Healthcare leaders

    Individuals who are accountable and responsible for the operational, clinical, and/or strategic delivery of stroke rehabilitation, rehabilitation and/or therapy services within a NHS hospital * Individuals working in an Integrated Care Board with rehabilitation and/or research in their portfolio * Experience in implementing/influencing stroke rehabilitation policy/service delivery

    Other: Co-designing a stroke rehabilitation toolkit

  • Stroke rehabilitation researchers

    Active researchers with experience in designing, conducting and evaluating stroke rehabilitation or physical rehabilitation research * Affiliated with academic or research institutions * Willing to participate in co-design activities and share their perspectives.

    Other: Co-designing a stroke rehabilitation toolkit

  • Stroke rehabilitation funders

    * Currently employed, contracted to, or formally affiliated with a research funding organisation that reviews, commissions or funds stroke rehabilitation research (e.g., NIHR, Stroke Association, research councils, medical research councils, professional bodies or research charities) * Direct involvement in decision-making, monitoring or governance of stroke rehabilitation research within the past two years * Experience with funding processes related to stroke rehabilitation, rehabilitation or clinical trial oversight

    Other: Co-designing a stroke rehabilitation toolkit

  • Family member or friend of stroke survivor

    * Adults (aged 18+) who are a family member, friend, or informal caregiver of a stroke survivor. * Able and willing to provide informed consent. * Willing to participate in co-design activities and share their perspectives.

    Other: Co-designing a stroke rehabilitation toolkit

Interventions

  • OtherCo-designing a stroke rehabilitation toolkit

    STAGE 1 NATIONAL ONLINE SURVEY: to capture a broad range of views from those involved in stroke rehabilitation trials, e.g. all groups. This will help identify key themes for deeper exploration in STAGE 2. STAGE 2 INTERVIEWS: with up to 14 participants, a mix of research partners. Interviews will be online via Zoom or Microsoft Teams. Interviews will be audio recorded. A short film, called a catalyst film, will be created from the survey and interviews. STAGE 3 JOINT DISCUSSIONS: Approximately 16 participants; a mix of all groups will attend a 2-hour joint event. The catalyst film created from STAGES 1 and 2 will be shown. STAGE 4 CO-DESIGN WORKSHOPS: Three co-design workshops will take place over the course of 8 weeks. Up to 20 participants (a mix of groups). STAGE 5: CELEBRATION EVENT: showcase the co-designed outcomes, celebrate participant contributions, and share learning with wider stakeholders.

06

What researchers measure

Primary outcomes

  1. Survey, individual interviews, and group discussions This is co-design research the output will be the co-designed toolkit.

    STAGE 1 SURVEYS: Total number of surveys completed which will be categorised by participant groups, e.g., stroke survivors, family/friend of stroke survivor, stroke rehabilitation staff, healthcare leader, stroke rehabilitation researcher, funder. Data will be analysed as follows: * Descriptive statics (frequencies, percentages, and median responses) * Statistical tests (t-tests, ANOVA, correlation) STAGE 2 INTERVIEWS: Data will be analysed using thematic analysis which will inform stages 3 and 4. STAGE 3 JOINT DISCUSSIONS: Approximately 16 participants; a mix of all groups will attend a 2-hour joint event. STAGE 4 CO-DESIGN WORKSHOPS: Three co-design workshops will take place over the course of 8 weeks. Up to 20 participants (a mix of groups).

    Time frame: Time Frame: From March 2026 to February 2027

07

Study locations

1 site
  • University of Plymouth, Faculty of Health
    Plymouth, Devon PL4 6AB, United Kingdom
08

References and documents

Publications

  • Barac R, Stein S, Bruce B, Barwick M. Scoping review of toolkits as a knowledge translation strategy in health. BMC Med Inform Decis Mak. 2014 Dec 24;14:121. doi: 10.1186/s12911-014-0121-7. PubMed 25539950 ↗
  • Hempel S, O'Hanlon C, Lim YW, Danz M, Larkin J, Rubenstein L. Spread tools: a systematic review of components, uptake, and effectiveness of quality improvement toolkits. Implement Sci. 2019 Aug 19;14(1):83. doi: 10.1186/s13012-019-0929-8. PubMed 31426825 ↗
  • Logan A, Marsden J, Freeman J, Cork E, Kent B. Optimising adherence to inpatient rehabilitation trial protocols: A mixed-methods systematic review. Clin Trials. 2025 Dec;22(6):728-744. doi: 10.1177/17407745251358262. Epub 2025 Nov 6. PubMed 41195536 ↗
  • Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, Dobbels F, Fargher E, Morrison V, Lewek P, Matyjaszczyk M, Mshelia C, Clyne W, Aronson JK, Urquhart J; ABC Project Team. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012 May;73(5):691-705. doi: 10.1111/j.1365-2125.2012.04167.x. PubMed 22486599 ↗
  • Stinear CM, Lang CE, Zeiler S, Byblow WD. Advances and challenges in stroke rehabilitation. Lancet Neurol. 2020 Apr;19(4):348-360. doi: 10.1016/S1474-4422(19)30415-6. Epub 2020 Jan 28. PubMed 32004440 ↗

Related links

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Feb 2026 (actual). Primary completion is estimated for Jan 2027, 11 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 10, 2026
First posted
Mar 20, 2026
StartActual
Feb 26, 2026
Primary completionEst.
Jan 31, 2027
CompletionEst.
Dec 31, 2027
Last update
Mar 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07484958
Lead sponsor
University of Plymouth
Collaborators
Royal Devon and Exeter NHS Foundation Trust
Responsible party
Jon Marsden (Professor of Rehabilitation, University of Plymouth) — Principal investigator
First posted
Mar 20, 2026
Start date
Feb 26, 2026
Primary completion
Jan 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Mar 20, 2026

Study contacts

Jonathan Marsden, PhD
principal investigator · University of Plymouth
Angie Logan, PhD
study director · University of Plymouth

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion